Article Contents ::
- 1 The Brand Name ARKAMIN-H Has Generic Salt :: Clonidine
- 2 ARKAMIN-H Is From Company Unichem Priced :: Rs. 10.25
- 3 ARKAMIN-H have Clonidine is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name ARKAMIN-H Has Generic Salt :: Clonidine
ARKAMIN-H Is From Company Unichem Priced :: Rs. 10.25
ARKAMIN-H have Clonidine is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| Clonidine | TAB | Rs. 10.25 | 10 |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 10 |
| ARKAMIN-H | Unichem | 100MCG,20MG | 10 | Rs. 10.25 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From Unichem :: ARKAMIN-H | Clonidine | #N/A | #N/A |
Indications for Drugs ::
Hypertension, Anxiety disorders, Migraine, Panic disorder, Menopausal flushing, Hypertensive crisis, Cancer pain
Drug Dose ::
Adult: PO HTN Initial: 50-100 mcg 3 times/day. Max: 2,400 mcg/day. Menopausal flushing; Migraine prophylaxis 50 mcg twice daily, up to 75 mg twice daily. Renal impairment: Supplemental doses after haemodialysis are not necessary. CrCl (ml/min) <10 50-75% of usual dose. Contraindication ::
Hypersensitivity. Disorders of cardiac pacemaker activity and conduction. Pregnancy and lactation.
Drug Precautions ::
Withdraw gradually, renal impairment, tasks that require mental alertness. Cerebrovascular disease, ischaemic heart disease, MI. IV inj should be administered slowly. Occlusive peripheral vascular disorders, history of depression.
Drug Side Effects ::
Dry mouth, drowsiness, dizziness, headache, constipation, impotence, vivid dreams, urinary retention; dry, itching, burning sensation in the eye; fluid or electrolyte imbalance, GI upset, paralytic ileus, orthostatic hypotension, weakness, sedation, pruritus, myalgia, urticaria, nausea, insomnia, arrhythmias, agitation. Reduced GI motility at times may cause paralytic ileus. Potentially Fatal: Transient hypertension or profound hypotension, respiratory depression, convulsion. Clonidine withdrawal syndrome could be life threatening. Bradycardia, coma and disturbances in conduction (in individuals with preexisting diseases of SA/AV nodes, overdose or on digitalis).
Pregnancy category ::
3
Drug Mode of Action ::
Clonidine stimulates alpha-2 receptors in brain stem which results in reduced sympathetic outflow from the CNS and a decrease in peripheral resistance leading to reduced BP and pulse rate. It does not alter normal haemodynamic response to exercise at recommended dosages.
Drug Interactions ::
Hypotensive action may be potentiated by diuretics and vasodilators. Effects of clonidine antagonised by TCAs and centrally-acting alpha-blockers. May enhance toxicity due to digitalis, lithium. May antagonise oral hypoglycaemics. Potentially Fatal: Hypnosedatives, antihistamines and alcohol may cause excessive drowsiness in patients on clonidine. Withdrawal of clonidine in patients receiving noncardioselective ?-blockers may result in rebound BP. Acute severe hypotension following concomitant administration of clonidine and chlorpromazine or haloperidol.
